- Senseonics (NYSEMKT:SENS) has filed a supplemental marketing application in the U.S. seeking approval to extend the wearable life of the Eversense CGM System to 180 days from the current 90 days.
- The company says the next-generation system features an improved algorithm and reduced calibration scheme, requiring only one per day.
- If approved, partner Ascensia Diabetes Care will distribute.
- https://seekingalpha.com/news/3619729-senseonics-files-u-s-application-to-extend-wearable-life-of-glucose-monitor
Monday, October 5, 2020
Senseonics files U.S. application to extend wearable life of glucose monitor
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.